AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, consumer product dispensing and active material science solutions, announced the dates and times of quarterly conference calls for the year. Any updates to these dates or times will be communicated in subsequent press releases.
Quarterly Conference Calls
Press Release (1)
Conference Call (2)
4th Quarter and Annual 2021 Results
February 17, 2022
February 18, 2022, at
8:00 a.m. CT
1st Quarter 2022 Results
April 28, 2022
April 29, 2022, at
8:00 a.m. CT
2nd Quarter 2022 Results
July 28, 2022
July 29, 2022, at
8:00 a.m. CT
3rd Quarter 2022 Results
October 27, 2022
October 28, 2022, at
8:00 a.m. CT
(1)
Press releases will be issued on the dates noted after the close of trading on the New York Stock Exchange.
(2)
Times shown are in the Central U.S. time zone. Conference calls will last approximately one hour and interested parties are invited to listen to a live webcast by visiting investors.aptar.com. Replay of the conference calls can also be accessed on the Investors page of the website.
About Aptar
Aptar is a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar’s innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005970/en/
AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.